Castle Biosciences Inc (NAS:CSTL)
$ 24.37 0.63 (2.65%) Market Cap: 672.79 Mil Enterprise Value: 458.63 Mil PE Ratio: 0 PB Ratio: 1.67 GF Score: 79/100

Castle Biosciences Inc at JMP Securities Life Sciences Conference Transcript

Jun 16, 2022 / 02:30PM GMT
Release Date Price: $16.03 (-5.48%)
Unidentified Analyst

Thank you, everybody, for joining us for the JMP Securities Life Sciences Conference. So, the next company we have presenting is Castle Biosciences. We have Derek Maetzold, CEO; and Frank Stokes, CFO, are presenting.

Derek Maetzold
Castle Biosciences, Inc. - Founder, President & CEO

Thank you, [Ryan]. Thank you for JMP Securities for organizing this conference -- in person actually.

I am going to -- have started with our standard corporate deck, which I'm going to skip through a number of slides. You can find that on our website, obviously, but we'll go and give you a quick overview, in about 20 minutes, of Castle Biosciences -- where we are today; where we think we're going tomorrow.

First of all is the disclaimer slide, which you all can read in your own time.

So, who are we? We are a molecular diagnostics company[DN1] which is focused on transforming patient care through innovative diagnostic tests, and we focus in a pattern of fours, I guess you would say.

Our first goal is to look for high unmet

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot